Loading Video…
This browser does not support the Video element.
Rasonque: FDA approves pancreatic cancer pill
The Food and Drug Administration approved a once-a-day pill for advanced pancreatic cancer more than six months ahead of target.
This browser does not support the Video element.
The Food and Drug Administration approved a once-a-day pill for advanced pancreatic cancer more than six months ahead of target.